Wyeth Paying $491M To End Criminal, Civil Rapamune Cases

Wyeth Paying $491M To End Criminal, Civil Rapamune Cases

Wyeth Pharmaceuticals Inc. has agreed to shell out $491 million to end a criminal action as well as civil False Claims Act cases alleging it illegally marketed its immunosuppressive drug Rapamune for unapproved uses, the U.S. Department of Justice said ...read more

  • Tags: